In 2009 Dinarello et al. described IL-32 as a critical regulator of endothelial cell function, possibly promoting atherosclerosis by potentiating IL-1β-induced ICAM-1 and by producing pro-inflammatory cytokines in these cells21. Here, IL32 is linked to atherosclerosis.